[e-drug] Use of generic or brand names in prescriptions (10)

e-drug
1

E-DRUG: Use of generic or brand names in prescriptions
-------------------------------------------------------------------------

[This has been a useful discussion and many valuable points have been made. I would suggest to close this discussion now. HH. Moderator]

Dear all,

I agree with Mr.Nadeem on the current sad situation applicable to most
developing countries.Not only quality testing, post-marketing surreivalance
studies and pharmocovigilance are lacking.we have large number of pharmacy
schools.A PG student can also check quality and quantity of a formulation
very easily.The faculty of pharmacy schools have to be mobilized to take up
testing of generics.We need to find solutions rather than blame darkness.

Bhava Narayana
Editor, Pharmed Trade News, India

--
V.BHAVA NARAYANA
EDITOR&PUBLISHER
PHARMED TRADE NEWS
3-3-62A,NEW GOKHALE NAGAR
RAMNTHAPUR. HYDERABAD 500 013
INDIA
Tel: 91-04027030681 MO 91-98495-51183
E-mail: pharmedtradenews@gmail.com
url: www.pharmedtradenews.com

2

E-DRUG: Request for information on TB drug regimens
---------------------------------------------------------------------

Dear Forum,

I am collecting information on regimens used under each treatment category -
Cat I, Cat II and Cat III and the cost of TB drugs for each completed
treatment in various countries.

I shall be grateful for all contributions. If the information is available
on any website, please send me the link.

Thanks and regards,

Dr Vineet Bhatia, MD
Manager - Procurement and Contracts
India Resource Centre
International Union Against Tuberculosis and Lung Disease (The Union)
C-6 Qutub Institutional area
Delhi - 110016, India
Tel: + 91-11-46054408
Mobile: +91-9811304577
Fax: + 91-11-46054430
e-mail: vbhatia@iuatld.org
skype: bhatiavineet
website: www.iuatld.org

3

E-DRUG: Request for information on TB drug regimens
---------------------------------------------------------------

Dear Dr Vineet Bhatia,

I hope you have seen the chart on "Treatment and Diagnosis Under RNTCP".
In this chart both "Diagnostic Algorithm for Pulmonary TB" and "Treatment
Regimens" are given along with all regimens and type of patients category
wise (I, II and III). Under the Revised National Tuberculosis Control
Program (RNTCP), all drugs are available free of cost at all DOTS
Centre due to kind courtesy of National TB Control Society, Indian Medical
Association and Global Funds for AIDS, Malaria and TB.

With best wishes,

Syed Ziaur Rahman

Lecturer
Department of Pharmacology
Jawaharlal Nehru Medical College
AMU, Aligarh 202002, India
E-mail: ibnsinaacademy@gmail.com